Polymyxin B (Athenex Pharmaceutical Division, LLC.)
Welcome to the PulseAid listing for the Polymyxin B drug offered from Athenex Pharmaceutical Division, LLC.. This Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Athenex Pharmaceutical Division, LLC. |
NON-PROPRIETARY NAME: | polymyxin B sulfate |
SUBSTANCE NAME: | POLYMYXIN B SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] |
ROUTE: | INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-01-01 |
END MARKETING DATE: | 0000-00-00 |
Polymyxin B HUMAN PRESCRIPTION DRUG Details:
Item Description | Polymyxin B from Athenex Pharmaceutical Division, LLC. |
LABELER NAME: | Athenex Pharmaceutical Division, LLC. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500000([iU]/1) |
START MARKETING DATE: | 2017-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70860-103_64391500-65a5-4d71-9abd-a916f7d7a12d |
PRODUCT NDC: | 70860-103 |
APPLICATION NUMBER: | ANDA207322 |
Other POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers: